S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:CPAH

CounterPath (CPAH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$3.47
$3.49
50-Day Range
$3.44
$3.49
52-Week Range
$1.84
$5.92
Volume
74,600 shs
Average Volume
31,350 shs
Market Capitalization
$22.41 million
P/E Ratio
34.80
Dividend Yield
N/A
Price Target
N/A
CPAH stock logo

About CounterPath Stock (NASDAQ:CPAH)

CounterPath Corporation designs, develops, and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications services over Internet protocol based networks in North America and internationally. Its products include Bria softphone suite that enables consumers and business users to make VoIP audio and video calls, send instant messages, manage their presence, share their screen, and collaborate with other users using desktop computers and laptops, smartphones, and tablets; and Bria Solo, which offers individual users to deploy their own softphones for use against SIP-based call sever. The company also offers software development kits that deliver voice, video, and messaging capabilities for desktop computers and mobile devices; Stretto Platform, a carrier-grade software platform for enterprises and service providers; Bria Teams, which delivers centralized provisioning, messaging, presence, screen sharing, video conferencing, and collaboration; and Bria Enterprise, an application for enterprises, service providers, and telecommunication channel partners to leverage the Stretto Platform to procure, distribute, provide, and manage Bria Enterprise clients from the cloud; and hosted messaging and collaboration solutions. In addition, it provides subscription, support, and maintenance services; and professional and other services, such as product configuration and customization, implementation, engineering, and training. The company sells its products and services through its own and third-party online stores; directly using its in-house sales team; and its channel partners. It serves small, medium, and large enterprises; telecommunications service providers and Internet telephony service providers; original equipment manufacturers, value added distributors, and value added resellers serving the telecommunication market; and end users. The company was founded in 2002 and is headquartered in Vancouver, Canada.

CPAH Stock News Headlines

Think Out Loud
Why CounterPath (CPAH) Stock Is Soaring Today
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
See More Headlines
Receive CPAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CounterPath and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/14/2016
Today
4/17/2024

Industry, Sector and Symbol

Industry
Prepackaged Software
Sub-Industry
N/A
Current Symbol
NASDAQ:CPAH
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

Net Income
$-1,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$12.10 million
Book Value
$0.33 per share

Miscellaneous

Free Float
N/A
Market Cap
$22.41 million
Optionable
Not Optionable
Beta
1.76
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. David L. Karp (Age 56)
    Pres & CEO
    Comp: $326.97k
  • Mr. Todd Carothers (Age 51)
    Chief Revenue Officer
    Comp: $317.26k
  • Ms. Karen Luk (Age 39)
    VP of Fin., Treasurer, Corp. Sec., Principal Accounting Officer (Leave of Absence)
    Comp: $101.05k
  • Mr. Srinivasa Janaswamy (Age 55)
    Interim VP of Fin., Sec., Treasurer, Principal Financial & Accounting Officer
  • Mr. Michael Doyle Bsc
    VP of Technology
  • Steven Hards
    VP of Investor Relations
  • Mr. Nemer D. Abourizk
    Gen. Counsel
  • Mr. John Wigboldus
    Sr. VP of Sales
  • Ms. Hanna Miller
    VP of Marketing
  • Mr. Bruce Ford
    Sr. VP of Strategic Bus. Devel.

CPAH Stock Analysis - Frequently Asked Questions

How were CounterPath's earnings last quarter?

CounterPath Co. (NASDAQ:CPAH) issued its quarterly earnings results on Wednesday, December, 14th. The software maker reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.10) by $0.02. The software maker had revenue of $2.75 million for the quarter, compared to the consensus estimate of $3.30 million. CounterPath had a net margin of 5.30% and a trailing twelve-month return on equity of 25.68%.

What other stocks do shareholders of CounterPath own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CounterPath investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), FuelCell Energy (FCEL), VBI Vaccines (VBIV), iBio (IBIO), AT&T (T), Inovio Pharmaceuticals (INO), Sierra Oncology (SRRA) and Biocept (BIOC).

This page (NASDAQ:CPAH) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners